Lucid Diagnostics Inc. — Director's Dealing 2024

May 8, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lucid Diagnostics Inc. (LUCD)
CIK: 0001799011
Period of Report: 2024-05-07

Reporting Person: O'Neil Shaun (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-07	Common stock	A	400000	—	Acquired	526763	Direct

Footnotes

F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2026. Such restricted stock is subject to forfeiture if the requisite service period is not completed.

F2: Includes 6,763 shares of Lucid common stock distributed by PAVmed on February 15, 2024 to Mr. O'Neil, representing his share of the shares of Lucid common stock distributed by PAVmed to its shareholders on a pro rata basis on such date.